Stable improvement of renal function after initiation of highly active anti-retroviral therapy in patients with HIV-1-associated nephropathy

Nephrology Dialysis Transplantation

Volumn 17, Issue 10, 2002, Pages 1836-1839

  Betjes, Michiel G H ^a   Verhagen, Dominique W M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ACE inhibition; Anti retroviral therapy; Glomerulosclerose; HIV 1; Nephropathy; Proteinuria

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CAPTOPRIL; CD4 ANTIGEN; CORTICOSTEROID DERIVATIVE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LAMIVUDINE; NEVIRAPINE; SERUM ALBUMIN; STAVUDINE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CASE REPORT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; EDEMA; FEMALE; HERPES ZOSTER OPHTHALMICUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; PNEUMONIA; PRIORITY JOURNAL; SEROLOGY; ULTRASOUND; VIRUS LOAD;

EID: 0036798122     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.10.1836     Document Type: Article

References (10)

1. Kimmel P. The nephropathies of HIV infection: pathogenesis and treatment. Curr Opin Nephrol Hypertens 2000; 9: 117-122
2. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997; 100: 84-92
3. Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E. HIV-1 associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998; 352: 783-784
4. Szcech LA, van der Horst C, Bartlett JA, Heald AE, Svetkey LP. Protease inhibitors are associated with a slowed progression of HIV-associated nephropathy. J Am Soc Nephrol 1999; 10: A0595
5. Winston JA, Bruggeman LA, Ross MD et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Eng J Med 2001; 344: 1979-1984
6. Schwartz EJ, Cara A, Snoeck H et al. Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 2001; 12: 1677-1684
7. Eitner F, Cui F, Hudkins KL, Stokes MB, Segerer S, Mack M. Chemokine receptor CCR5 and CXCR4 expression and HIV-1 detection in HIV-associated kidney disease. J Am Soc Nephrol 2000; 11: 856-867
8. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early manifestation of HIV-1 infection. Kidney Int 1999; 55: 1036-1040
9. Briggs WA, Tanawattanacharoen S, Choi MJ, Scheel PJ, Nadasdy T, Racusen L. Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 1996; 28: 618-621
10. Bird JF, Durham SK, Giancarli MR et al. Captopril prevents nephropathy in HIV-transgenic mice. J Am Soc Nephrol 1998; 9: 1441-1447